RetinalGenix Technologies Inc. RTGN
3.99 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
4.00 Day range 4.00
3.20 52-week range 4.00
- YTD
- +24.69%
- 1 year
- +12.39%
- Market cap
- 75.19M
- EPS (ttm)
- -0.11
- YTD return
- +24.69%
- 1-year return
- +12.39%
- Volume
- 18
- Avg volume
- 10
- Open
- 4.00
- Previous close
- 3.99
- Day's range
- 4.00 – 4.00
- 52-week range
- 3.20 – 4.00
2Y +0.49 (+14.00%)
News
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study 
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO 
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases 
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases 
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care 
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening 
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives 
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs 
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference 
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Your note
Sign in to keep a note on RTGN — it syncs with the Stock Master app.